GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmsynthez PJSC (MIC:LIFE) » Definitions » Price-to-Owner-Earnings

Pharmsynthez PJSC (MIC:LIFE) Price-to-Owner-Earnings : (As of Jun. 10, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Pharmsynthez PJSC Price-to-Owner-Earnings?

As of today (2024-06-10), Pharmsynthez PJSC's share price is ₽5.50. Pharmsynthez PJSC does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Pharmsynthez PJSC's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Pharmsynthez PJSC was 372.31. The lowest was 58.31. And the median was 82.96.


MIC:LIFE's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.7
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-10), Pharmsynthez PJSC's share price is ₽5.50. Pharmsynthez PJSC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was ₽-1.01. Therefore, Pharmsynthez PJSC's PE Ratio for today is At Loss.

As of today (2024-06-10), Pharmsynthez PJSC's share price is ₽5.50. Pharmsynthez PJSC's EPS without NRI for the trailing twelve months (TTM) ended in was ₽-1.05. Therefore, Pharmsynthez PJSC's PE Ratio without NRI for today is At Loss.

During the past 13 years, Pharmsynthez PJSC's highest PE Ratio without NRI was 24.46. The lowest was 0.00. And the median was 19.82.


Pharmsynthez PJSC Price-to-Owner-Earnings Historical Data

The historical data trend for Pharmsynthez PJSC's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmsynthez PJSC Price-to-Owner-Earnings Chart

Pharmsynthez PJSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.17 - - - -

Pharmsynthez PJSC Semi-Annual Data
Dec11 Jun13 Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharmsynthez PJSC's Price-to-Owner-Earnings

For the Biotechnology subindustry, Pharmsynthez PJSC's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmsynthez PJSC's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmsynthez PJSC's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Pharmsynthez PJSC's Price-to-Owner-Earnings falls into.



Pharmsynthez PJSC Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Pharmsynthez PJSC's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=5.50/-0.29
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmsynthez PJSC  (MIC:LIFE) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Pharmsynthez PJSC Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Pharmsynthez PJSC's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmsynthez PJSC (MIC:LIFE) Business Description

Traded in Other Exchanges
N/A
Address
150 Engelsa Prospect, St. Petersburg, RUS, 194358
Pharmsynthez PJSC is a pharmaceutical company developing new medications, technologies of drugs for organ-specific delivery and innovative methods of manufacture for pharmaceutical ingredients. The company is engaged in the research and development, production and sales of officinal medicines (original OM) and active pharmaceutical ingredients (API).

Pharmsynthez PJSC (MIC:LIFE) Headlines

No Headlines